Concomitant stress urinary incontinence and pelvic organ prolapse surgery: Opportunity or overtreatment?
- PMID: 32387890
- DOI: 10.1016/j.ejogrb.2020.04.057
Concomitant stress urinary incontinence and pelvic organ prolapse surgery: Opportunity or overtreatment?
Abstract
Objectives: The association between pelvic organ prolapse (POP) and stress urinary incontinence (SUI) is very common. When POP surgery is indicated and the patient has concomitant SUI, there are two treatment strategies: the one-step strategy (concomitant correction of POP and SUI) and the two-step strategy (correction of POP with subsequent evaluation of SUI). Guidelines from the International Continence Society and International Consultation on Incontinence recommend that a urodynamic assessment (UA) should be performed before surgery as this can reveal the presence of urodynamic SUI, but the role of UA is the subject of debate as it does not seem to improve treatment decisions. The aim of this study was to identify the presence of pre-operative urodynamic parameters that were predictive of POSUI, and to identify patients who could benefit from concomitant correction of SUI during POP surgery STUDY DESIGN: A retrospective evaluation was undertaken of 155 patients with at least second-degree POP who underwent POP surgery after UA between 2009 and 2016 in an Italian gynaecology and obstetrics department. Of these, 61 patients were clinically incontinent before surgery and 94 patients were clinically continent. After UA, patients were stratified using a maximum urethral closure pressure (MUCP) cut-off of 50 cmH2O; the risk of POSUI was calculated using this value.
Results: POP surgery alone resolved SUI in 60 % of the 61 clinically incontinent patients; only 30 % of these patients had urodynamic SUI and >50 % did not have POSUI. Thirty-six percent of the 94 continent patients had occult SUI on UA and 16 % developed de-novo POSUI. Seventy-five percent of all patients with occult SUI did not develop de-novo SUI. MUCP was lower in patients with POSUI than in patients without POSUI (p=0.013). The probability of POSUI was higher in patients with MUCP ≤50 cmH2O. The number needed to treat (NNT) to prevent one case of POSUI in these patients was 2, compared with an NNT of 4 in the continent group. Eight percent of patients underwent further surgery for SUI.
Conclusions: Clinically incontinent patients with MUCP ≤50 cmH2O will gain the greatest benefit from concomitant POP and SUI surgery. However, concomitant surgery has more severe adverse events. Given that 62.3 % of patients resolved SUI after POP surgery alone, it is important not to overtreat these women. Clinical pre-operative SUI is the best indicator of POSUI and was found to increase the risk of POSUI (odds ratio 3.2, 95 % confidence interval 1.5-6.8; p=0.003). Despite the small sample size, the two-step strategy appears to result in lower use of mid-urethral slings and a clear reduction in complications. It is important not to focus on the diagnosis of urodynamic SUI in continent patients but to evaluate MUCP carefully.
Keywords: Prolapse surgery; Stress urinary incontinence; Urodynamics.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None declared.
Similar articles
-
The predictive value of demonstrable stress incontinence during basic office evaluation and urodynamics in women without symptomatic urinary incontinence undergoing vaginal prolapse surgery.Neurourol Urodyn. 2018 Mar;37(3):1011-1018. doi: 10.1002/nau.23384. Epub 2017 Aug 23. Neurourol Urodyn. 2018. PMID: 28834564
-
External validation of a model predicting de novo stress urinary incontinence after pelvic organ prolapse surgery.Neurourol Urodyn. 2021 Feb;40(2):688-694. doi: 10.1002/nau.24608. Epub 2021 Jan 25. Neurourol Urodyn. 2021. PMID: 33492730
-
Changes in urodynamic measurements and bladder neck position after single-incision trans-vaginal mesh for pelvic organ prolapse.Int Urogynecol J. 2015 Nov;26(11):1629-35. doi: 10.1007/s00192-015-2753-2. Epub 2015 Jul 10. Int Urogynecol J. 2015. PMID: 26156205
-
Management of occult stress urinary incontinence with prolapse surgery.Minerva Ginecol. 2013 Aug;65(4):417-24. Minerva Ginecol. 2013. PMID: 24051941 Review.
-
Prevalence and management of urinary incontinece after pelvic organ prolapse surgery (sacrocolpopexy). A literature review.Actas Urol Esp (Engl Ed). 2024 Sep;48(7):490-496. doi: 10.1016/j.acuroe.2024.02.008. Epub 2024 Feb 16. Actas Urol Esp (Engl Ed). 2024. PMID: 38369286 Review. English, Spanish.
Cited by
-
The Impact of Pelvic Organ Prolapse on the Long-Term Outcomes of Transobturator Tape (TOT) Procedures-A Retrospective Study.J Clin Med. 2024 Dec 30;14(1):159. doi: 10.3390/jcm14010159. J Clin Med. 2024. PMID: 39797242 Free PMC article.
-
Is There a Role for Urodynamic Investigation in the Management of Pelvic Organ Prolapse?J Clin Med. 2025 Feb 11;14(4):1163. doi: 10.3390/jcm14041163. J Clin Med. 2025. PMID: 40004694 Free PMC article. Review.
-
Surgical Procedures for the Treatment of Stress Urinary Incontinence (SUI) in the Light of the Updated FDA-Warning and its Effects on Practice Patterns in Germany between 2010 and 2021.Geburtshilfe Frauenheilkd. 2024 Mar 6;84(3):256-263. doi: 10.1055/a-2243-2341. eCollection 2024 Mar. Geburtshilfe Frauenheilkd. 2024. PMID: 38455998 Free PMC article.
-
Clinical Efficacy of LSC and TVT-O for Stress Urinary Incontinence Complicated with Pelvic Organ Prolapse and Factors Influencing Postoperative Urinary Function Recovery.J Healthc Eng. 2022 Mar 7;2022:1557256. doi: 10.1155/2022/1557256. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Jul 12;2023:9870672. doi: 10.1155/2023/9870672. PMID: 35295170 Free PMC article. Retracted.
-
De novo urinary incontinence and lower urinary tract symptoms after colpocleisis: A single-center prospective study.Heliyon. 2024 May 7;10(10):e30805. doi: 10.1016/j.heliyon.2024.e30805. eCollection 2024 May 30. Heliyon. 2024. PMID: 38813205 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical